China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Artificial Intelligence-Assisted Insulin Pump Titration in Hospitalized Patients with Type 2 Diabetes: A Randomized Controlled Trial'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130423
Registration Time: 2026/08/19
Type: Interventional study
Primary Sponsor: Shanghai Fourth People’s Hospital, School of Medicine, Tongji University,
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=327208
Published by HT Digital Content Services with permission from Health Daily Digest....